Cigna Corporation Company Profile (NYSE:CI)

Cigna Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "CI."

Cigna Corporation announced a quarterly dividend on Wednesday, February 22nd. Stockholders of record on Friday, March 10th will be paid a dividend of $0.04 per share on Monday, April 10th. This represents a $0.16 dividend on an annualized basis and a dividend yield of 0.08%. The ex-dividend date is Wednesday, March 8th. View Cigna Corporation's Dividend History.

Cigna Corporation declared that its Board of Directors has authorized a share repurchase plan on Sunday, June 4th 2017, which allows the company to buyback $3,700,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to purchase up to 9.8% of its stock through open market purchases. Stock buyback plans are generally a sign that the company's leadership believes its stock is undervalued.

Cigna Corporation (NYSE:CI) announced its earnings results on Friday, August, 4th. The company reported $2.91 EPS for the quarter, topping the consensus estimate of $2.48 by $0.43. The business earned $10.32 billion during the quarter, compared to analysts' expectations of $10.26 billion. Cigna Corporation had a return on equity of 17.40% and a net margin of 5.55%. The business's revenue was up 3.6% on a year-over-year basis. During the same period in the previous year, the company posted $1.98 EPS. View Cigna Corporation's Earnings History.

Cigna Corporation is scheduled to release their next quarterly earnings announcement on Thursday, November, 2nd 2017. View Earnings Estimates for Cigna Corporation.

Cigna Corporation issued an update on its FY17 earnings guidance on Friday, August, 4th. The company provided EPS guidance of $9.75-10.05 for the period, compared to the Thomson Reuters consensus estimate of $9.78.

14 brokerages have issued 12-month price targets for Cigna Corporation's shares. Their predictions range from $174.00 to $221.00. On average, they expect Cigna Corporation's share price to reach $192.00 in the next twelve months. View Analyst Ratings for Cigna Corporation.

Here are some recent quotes from research analysts about Cigna Corporation stock:

• 1. According to Zacks Investment Research, "Cigna’s shares have outperformed the industry year to date. The company is poised for long-term growth on the back of its robust Global Supplemental business, growing Government business and increasing membership. A strong capital position and resumption of share buyback are other positives. The stock has seen the Zacks Consensus Estimate for current-year earnings being revised upward over the last 90 days. Cigna is engaged in a legal tussle with Anthem and thus the termination fee and other charges that it were to receive from the latter remain uncertain.  Increase in benefits and expenses continue to bother us." (10/9/2017)
• 2. Jefferies Group LLC analysts commented, "CI reported Q2:17 adjusted EPS of $2.91 (GAAP $3.15), compared to OPCO’s estimate of $2.46 and Street consensus of $2.45. Adjusted results exclude $0.13 of realized investment gains and $0.18 from merger-related tax benefits, offset by $0.07 of amortization expense. The beat was driven by the Healthcare segment, with the Commercial MCR of 78.7% outperforming OPCO/Street estimates by 200/160 bps. Due to the beat, the company raised FY2017 EPS guidance to $9.75-$10.05 vs. $9.35-$9.85, with all three segment outlooks growing by $15-$40M." (8/4/2017)

Some companies that are related to Cigna Corporation include Aetna (AET), Anthem (ANTM), Humana (HUM), Centene Corporation (CNC), WellCare Health Plans (WCG), Molina Healthcare (MOH), Magellan Health (MGLN), Triple-S Management Corporation (GTS), Catamaran Corp (CTRX), Catamaran Corp (SXCI) and Universal American (UAM).

Cigna Corporation's management team includes the folowing people:

• Isaiah Harris Jr., Independent Chairman of the Board
• David M. Cordani, President, Chief Executive Officer, Director
• Eric P. Palmer, Chief Financial Officer, Executive Vice President
• CHRISTOPHER HOCEVAR, President, Strategy, Segments and Solutions
• Matthew G. Manders, President - Government & Individual Programs and Group Insurance
• Jason Dominic Sadler, President - International Markets.
• MICHAEL TRIPLETT, is President, U.S. Markets
• Mark L. Boxer, Global Chief Information Officer, Executive Vice President
• Lisa R. Bacus, Executive Vice President, Chief Marketing Officer, Chief Customer Officer
• Nicole S. Jones, Executive Vice President, General Counsel

Cigna Corporation's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Pensionfund DSM Netherlands (0.01%), Pensionfund Sabic (0.00%) and Eqis Capital Management Inc. (0.00%). Company insiders that own Cigna Corporation stock include David Cordani, Herbert A Fritch, Isaiah Harris Jr, Isaiah Harris, Jr, Jane E Md Henney, Jason D Sadler, John M Murabito, Lisa R Bacus, Mary T Hoeltzel, Matthew G Manders, Michael W Triplett, Nicole S Jones, Thomas A Mccarthy and William D Zollars. View Institutional Ownership Trends for Cigna Corporation.

Cigna Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Pensionfund DSM Netherlands, Pensionfund Sabic and Eqis Capital Management Inc.. View Insider Buying and Selling for Cigna Corporation.

Shares of Cigna Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of Cigna Corporation stock can currently be purchased for approximately $189.36.